Obesity Beyond GLP-1s: Oral Formulations Take Center Stage Citeline News & Insights Weight loss drug frenzy: What’s here and what’s likely coming next msn.com Use of weight loss ‘wonder drugs’ has doubled. The Salk Institute is studying just how far their benefits can go msn.com US weight-loss drugmakers slash prices in fight to win customers BBC Source link
Another key concern is the growing demand for these drugs among individuals who are medically healthy but experience high levels of weight-related anxiety. Increasingly, GLP-1 medications are being sought not for disease management but for aesthetic or preventive reasons. The rise of telehealth platforms and targeted social media marketing has accelerated this trend, often positioning … Read more
We need your help now Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough. If you’ve seen value in our reporting, … Read more
Results from a recent population-based cohort study have indicated that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may increase the risk of developing neovascular age-related macular degeneration (nAMD) in patients with diabetes.1 GLP-1 RAs are one of the most beneficial treatments for type 2 diabetes; it increases glucose transporter expression in pancreatic cells, which facilitate glucose … Read more
Groundbreaking advancements in MASH cirrhosis treatment are rapidly emerging.Discover how GLP-1 and FGF21 analogs are reshaping the landscape of liver disease management,offering renewed hope for those affected. Recent studies highlight the potential of these novel drug therapies to significantly improve outcomes and revolutionize patient care. This article dives deep into the science, exploring the mechanisms … Read more
Streamlining GLP-1 prior Authorizations: A New Era of Efficiency The prior authorization (PA) process for glucagon-like peptide-1 (GLP-1) medications has long been a source of frustration for both health care providers and patients. The administrative burden, potential for errors, and resulting delays in treatment initiation can significantly impact patient outcomes. Tho, advancements in electronic prior … Read more
Semaglutide side effects solved? Scientists target nerve cells responsible for nausea-free weight loss nutritioninsight.com Scientists Flip the Brain’s “Fat-Off” Switch – Weight Loss Without Side Effects SciTechDaily Tiny Brain Cell Cluster Found to Drive Obesity and Overeating Neuroscience News Source link
Four leading organizations in lifestyle medicine, obesity medicine, and nutrition-the American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)-have jointly released a clinical advisory titled “Nutritional Priorities to Support GLP-1 Therapy for Obesity.” Published across four peer-reviewed journals, this consensus-based guidance reflects … Read more
“`html Table of Contents BREAKING: GLP-1 Access Improving, But Hurdles Remain Key Findings Limitations Noted Conclusion BREAKING: GLP-1 Access Improving, But Hurdles Remain By Amelia Smith | WASHINGTON… The post GLP-1 Coverage: Yearly Trends for Weight Loss 2024 appeared first on NewsyList. Source link
The Silent Risk: Why Type 2 Diabetes Impacts Women Differently Table of Contents The Silent Risk: Why Type 2 Diabetes Impacts Women Differently Delayed Diagnosis and Increased Severity in Women The Diagnostic Gap: Why Are Women Being Missed? The Role of Hormonal Fluctuations Pregnancy as a Predictive Factor The Shifting Landscape of Fat Storage Women … Read more